Home
>
National Drug Code (NDC)
>
Galantamine
Galantamine - 0555-0139-09 - (Galantamine)
Drug Information of Galantamine
| Product NDC: | 0555-0139 |
| Proprietary Name: | Galantamine |
| Non Proprietary Name: | Galantamine |
| Active Ingredient(s): | 8 mg/1 & nbsp; Galantamine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Galantamine
| Product NDC: | 0555-0139 |
| Labeler Name: | Barr Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077605 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080828 |
Package Information of Galantamine
| Package NDC: | 0555-0139-09 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (0555-0139-09) |
NDC Information of Galantamine
| NDC Code | 0555-0139-09 |
| Proprietary Name | Galantamine |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (0555-0139-09) |
| Product NDC | 0555-0139 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Galantamine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20080828 |
| Marketing Category Name | ANDA |
| Labeler Name | Barr Laboratories Inc. |
| Substance Name | GALANTAMINE HYDROBROMIDE |
| Strength Number | 8 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
